CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
For Physicians Managing Voiding Dysfunction, Improving the Detection Rate of Early Prostate Cancer and Discrimination From Benign Prostatic Hyperplasia, in a Molecular Biomarker Aspects
Won Tae Kim, Seok Joong Yun, Wun-Jae Kim
Int Neurourol J. 2019;23(1):5-12.   Published online 2019 March 31
DOI: https://doi.org/10.5213/inj.1836262.131

Excel Download

For Physicians Managing Voiding Dysfunction, Improving the Detection Rate of Early Prostate Cancer and Discrimination From Benign Prostatic Hyperplasia, in a Molecular Biomarker Aspects
International Neurourology Journal. 2019;23(1):5-12   Crossref logo
Link1 Link2 Link3

Incontinence (Benign Prostatic Hyperplasia/Prostate Dysfunction)
Comprehensive Medicinal Chemistry II. 2007;551-573   Crossref logo
Link1 Link2

Voiding dysfunction in benign prostatic hyperplasia: trends, controversies and recent revelations. I. symptoms and urodynamics
Urology. 1998;51(5):62-72   Crossref logo
Link1 Link2

Voiding dysfunction in benign prostatic hyperplasia: trends, controversies and recent revelations. II. pathology and pathophysiology
Urology. 1998;51(5):73-82   Crossref logo
Link1 Link2

Induction of apoptosis by α1-adrenoceptor antagonists in benign prostatic hyperplasia and prostate cancer
Prostate Cancer and Prostatic Diseases. 2000;3(S1):S24-S25   Crossref logo
Link1 Link2 Link3

Benign prostatic hyperplasia and prostate cancer: an overview for primary care physicians
International Journal of Clinical Practice. 2010;64(13):1740-1745   Crossref logo
Link1

Mortality and prostate cancer risk in 19 598 men after surgery for benign prostatic hyperplasia
BJU International. 1999;84(1):37-42   Crossref logo
Link1

Controlled-release doxazosin in the treatment of benign prostatic hyperplasia
Prostate Cancer and Prostatic Diseases. 2005;8(4):375-380   Crossref logo
Link1 Link2 Link3

Alpha–1–adrenoceptor blockade in the treatment of benign prostatic hyperplasia
Prostate Cancer and Prostatic Diseases. 1999;2(3):110-119   Crossref logo
Link1 Link2 Link3

Atlas of Urologic Clinics of North America: Treatment of Benign Prostatic Hyperplasia
Prostate Cancer and Prostatic Diseases. 2003;6(2):198-198   Crossref logo
Link1 Link2 Link3